Trials / Conditions / Spinal Muscular Atrophy Type III
Spinal Muscular Atrophy Type III
3 registered clinical trials studyying Spinal Muscular Atrophy Type III.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy NCT06137612 | University Hospital, Basel, Switzerland | — |
| Active Not Recruiting | Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi NCT04042025 | Novartis Gene Therapies | Phase 3 |
| Terminated | Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III NCT00439569 | Westat | Phase 1 / Phase 2 |